(19)
(11) EP 2 285 378 A1

(12)

(43) Date of publication:
23.02.2011 Bulletin 2011/08

(21) Application number: 09718970.8

(22) Date of filing: 05.03.2009
(51) International Patent Classification (IPC): 
A61K 31/4985(2006.01)
A61P 27/02(2006.01)
(86) International application number:
PCT/US2009/036119
(87) International publication number:
WO 2009/114373 (17.09.2009 Gazette 2009/38)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA RS

(30) Priority: 10.03.2008 US 35073 P

(71) Applicant: Sanofi-Aventis
75013 Paris (FR)

(72) Inventors:
  • OLIGINO, Thomas
    Bridgewater, New Jersey 08807 (US)
  • HAHN, Chang
    Bridgewater, New Jersey 08807 (US)
  • GILLESPY, Timothy A.
    Bridgewater, New Jersey 08807 (US)
  • DHARANIPRAGADA, Ramalinga
    Bridgewater, New Jersey 08807 (US)
  • MATZKIN, Ellen
    Bridgewater, New Jersey 08807 (US)

(74) Representative: Rauline, Mathilde et al
Sanofi-Aventis Département Brevets 174 Avenue de France
75013 Paris
75013 Paris (FR)

   


(54) TREATMENT FOR OCULAR-RELATED DISORDERS